Blair William & CO Catalent, Inc. Transaction History

Blair William & CO

$31.4 Billion
Q1 2024

A detailed history of Blair William & CO transactions in Catalent, Inc. stock. As of the latest transaction made, Blair William & CO holds 41,998 shares of CTLT stock, worth $2.43 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

41,998

Previous 40,778 2.99%

Holding current value

$2.43 Million

Previous $1.83 Million 29.37%

% of portfolio

0.01%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	BUY	$42.56 - $59.82 $51,923 - $72,980	1,220 Added 2.99%	41,998 $2.37 Million
Q4 2023 Feb 12, 2024	SELL	$32.18 - $46.57 $827,701 - $1.2 Million	-25,721 Reduced 38.68%	40,778 $1.83 Million
Q3 2023 Nov 09, 2023	SELL	$44.2 - $50.2 $208,933 - $237,295	-4,727 Reduced 6.64%	66,499 $3.03 Million
Q2 2023 Aug 11, 2023	SELL	$31.86 - $67.26 $919,097 - $1.94 Million	-28,848 Reduced 28.83%	71,226 $3.09 Million
Q1 2023 May 12, 2023	BUY	$45.44 - $74.26 $3.03 Million - $4.95 Million	66,658 Added 199.48%	100,074 $6.58 Million

Q4 2022 Feb 10, 2023	BUY	$41.39 - $81.0 $116,471 - $227,934	2,814 Added 9.2%	33,416 $1.5 Million
Q3 2022 Nov 09, 2022	SELL	$72.36 - $113.1 $31,404 - $49,085	-434 Reduced 1.4%	30,602 $2.21 Million
Q2 2022 Aug 10, 2022	SELL	$87.2 - $114.05 $62,958 - $82,344	-722 Reduced 2.27%	31,036 $3.33 Million
Q1 2022 May 13, 2022	SELL	$94.19 - $124.49 $19,026 - $25,146	-202 Reduced 0.63%	31,758 $3.52 Million
Q4 2021 Feb 14, 2022	BUY	$119.57 - $139.07 $248,586 - $289,126	2,079 Added 6.96%	31,960 $4.09 Million
Q3 2021 Nov 12, 2021	BUY	$109.17 - $142.35 $69,541 - $90,676	637 Added 2.18%	29,881 $3.98 Million
Q2 2021 Aug 12, 2021	SELL	$100.34 - $115.69 $81,777 - $94,287	-815 Reduced 2.71%	29,244 $3.16 Million
Q1 2021 May 13, 2021	SELL	$101.51 - $125.27 $83,339 - $102,846	-821 Reduced 2.66%	30,059 $3.17 Million
Q4 2020 Feb 09, 2021	SELL	$85.88 - $105.36 $69,476 - $85,236	-809 Reduced 2.55%	30,880 $3.21 Million
Q3 2020 Nov 06, 2020	SELL	$72.74 - $92.5 $506,270 - $643,800	-6,960 Reduced 18.01%	31,689 $2.71 Million
Q2 2020 Aug 12, 2020	BUY	$48.02 - $79.04 $322,550 - $530,911	6,717 Added 21.04%	38,649 $2.83 Million
Q1 2020 May 11, 2020	BUY	$36.95 - $62.95 $289,872 - $493,842	7,845 Added 32.57%	31,932 $1.66 Million
Q4 2019 Feb 13, 2020	BUY	$47.06 - $56.64 $211,534 - $254,596	4,495 Added 22.94%	24,087 $1.36 Million
Q3 2019 Nov 12, 2019	BUY	$47.45 - $58.05 $24,911 - $30,476	525 Added 2.75%	19,592 $934,000
Q2 2019 Aug 13, 2019	BUY	$39.26 - $54.21 $230,613 - $318,429	5,874 Added 44.52%	19,067 $1.03 Million
Q1 2019 May 14, 2019	BUY	$29.84 - $43.92 $52,816 - $77,738	1,770 Added 15.5%	13,193 $536,000
Q4 2018 Feb 14, 2019	SELL	$29.95 - $46.34 $321,752 - $497,830	-10,743 Reduced 48.47%	11,423 $356,000
Q3 2018 Nov 13, 2018	BUY	$40.12 - $45.55 $251,873 - $285,962	6,278 Added 39.51%	22,166 $1.01 Million
Q2 2018 Aug 13, 2018	SELL	$38.72 - $42.52 $4,065 - $4,464	-105 Reduced 0.66%	15,888 $666,000
Q1 2018 May 15, 2018	BUY	$39.4 - $47.39 $630,124 - $757,908	15,993 New	15,993 $657,000

Others Institutions Holding CTLT

# of Institutions

484

Shares Held

171M

Call Options Held

865K

Put Options Held

687K

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account